Medicare Enrolled

Dr. Sean Adrean, M.D.

Retina Specialist (Ophthalmology) Physician · Fullerton, CA
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Consulting-driven
301 W BASTANCHURY RD, Fullerton, CA 92835
7147384620
In practice since 2006 (19 years)
NPI: 1073566568 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Adrean from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Adrean? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Adrean

Dr. Sean Adrean is a retina specialist physician in Fullerton, CA, with 19 years of NPI registration. Based on federal Medicare data, Dr. Adrean performed 50,361 Medicare services across 4,108 unique beneficiaries.

Between the years covered by Open Payments, Dr. Adrean received a total of $35,077 from 33 pharmaceutical and/or device companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in retina specialist (ophthalmology) physician. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Adrean is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 7% volume in CA $35,077 industry payments

Medicare Practice Summary

Medicare Utilization ↗
50,361
Medicare services
Top 7% in CA for retina specialist (ophthalmology) physician
4,108
Unique beneficiaries
$61
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2,651 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Eye injection (Vabysmo/faricimab)
An injection of faricimab-svoa, a medication administered in 0.1 mg doses.
38,460 $29 $76
Retinal imaging (OCT scan)
This procedure involves imaging the retina to visualize its structure. It is used to examine the back of the eye.
3,141 $33 $127
Office visit, established patient (30-39 min)
A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition.
2,777 $108 $394
Eye injection for retinal disease
A procedure involving the administration of medication directly into the eye.
1,656 $110 $694
Aflibercept eye injection (Eylea) 1,304 $690 $1,798
Pegcetacoplan intravitreal injection, 1 mg
An injection of pegcetacoplan administered into the vitreous humor of the eye. The dose specified is 1 milligram.
1,035 $120 $307
Extended exam of back of eye with optic nerve drawing
A detailed examination of the posterior section of the eye, including the optic nerve, with documentation through drawing.
841 $13 $53
Retinal angiography with dye injection
This procedure uses a special camera to examine the blood vessels in the retina after a dye has been injected into the body.
302 $114 $446
Compounded drug, not otherwise classified
A medication prepared specifically for an individual patient by a pharmacist or physician, tailored to meet unique needs that cannot be fulfilled by commercially available products.
269 $74 $162
New patient office visit (45-59 min)
An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter.
182 $132 $545
Unclassified drug
A medication that does not fit into standard HCPCS or CPT classification categories.
102 $1,766 $6,570
Fluorescein angiography of retina
A special camera captures images of the blood vessels in the retina and the area between the white part of the eye and the retina after a dye is injected.
81 $234 $914
Retinal laser treatment for leaking blood vessels
This procedure uses a laser to seal leaking blood vessels in the retina. It is performed to prevent vision loss caused by fluid leakage from damaged retinal vessels.
40 $282 $1,570
Extended eye exam with retinal drawing
A detailed examination of the back of the eye that includes creating a drawing of the retina.
33 $22 $68
Eye exam, established patient, focused
A limited examination of the visual system for an existing patient. The provider focuses on a specific eye-related concern or symptom.
28 $82 $289
Ultrasound of eye tissue and structures
A diagnostic imaging test that uses sound waves to create pictures of the eye's internal tissues and structures.
25 $37 $148
Retinal membrane and internal limiting membrane removal
A surgical procedure to remove a membrane from the retina along with the internal limiting membrane of the retina.
24 $981 $4,036
Retinal photocoagulation to prevent detachment
This procedure uses laser light to create small burns on the retina. It is performed to help prevent the retina from detaching from the back of the eye.
19 $209 $820
Visual field test, extended
A test that maps your complete field of vision to detect blind spots or peripheral vision loss. Extended testing provides a more detailed assessment than a standard visual field exam.
18 $51 $215
Comprehensive eye exam, established patient
A comprehensive examination of the visual system performed for a patient who has previously been seen by the provider.
13 $105 $390
Office visit, established patient (20-29 min)
An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition.
11 $79 $299
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$35,077
Total received (2018-2024)
Avg $5,011/year across 7 years
Top 8% in CA for retina specialist (ophthalmology) physician
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
33
Companies
258
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$19,208 (54.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$9,605 (27.4%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$6,264 (17.9%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$2,614
2023
$10,610
2022
$2,259
2021
$2,251
2020
$1,973
2019
$11,598
2018
$3,771

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Alcon Vision LLC
$737
Apellis Pharmaceuticals, Inc.
$509
Regeneron Healthcare Solutions, Inc.
$269
Genentech USA, Inc.
$232
ABBVIE INC.
$193
Regeneron Pharmaceuticals, Inc.
$175
Cardinal Health 110 LLC
$150
Genentech, Inc.
$135
Astellas Pharma Global Development
$84
Coherus Biosciences Inc.
$51
Astellas Pharma US Inc
$34
Ocular Therapeutix, Inc.
$26
ANI Pharmaceuticals, Inc.
$18
Top 3 companies account for 57.9% of 2024 payments
All-time payments by company (2018-2024) ›
Genentech USA, Inc.
$10,297
Genentech, Inc.
$5,854
F. Hoffmann-La Roche AG
$4,938
Allergan Inc.
$3,066
Alimera Sciences, Inc.
$2,363
Alcon Vision LLC
$1,728
Allergan, Inc.
$1,566
Regeneron Healthcare Solutions, Inc.
$1,172
Apellis Pharmaceuticals, Inc.
$1,158
Alcon Laboratories Inc
$554
Regeneron Pharmaceuticals, Inc.
$513
Dutch Ophthalmic, USA
$242
AbbVie Inc.
$228
ABBVIE INC.
$218
Cardinal Health 110 LLC
$150
Novartis Pharmaceuticals Corporation
$132
Aerie Pharmaceuticals, Inc.
$125
Coherus Biosciences Inc.
$119
Johnson & Johnson Surgical Vision, Inc.
$90
Astellas Pharma Global Development
$84
Astellas Pharma US Inc
$82
OPTOS, INC.
$71
EyePoint Pharmaceuticals US, Inc.
$70
Biogen, Inc.
$48
Horizon Therapeutics plc
$43
Sight Sciences, Inc.
$26
Ocular Therapeutix, Inc.
$26
Mallinckrodt Hospital Products Inc.
$24
Bausch & Lomb, a division of Bausch Health US, LLC
$22
Thea Pharma Inc.
$20
ANI Pharmaceuticals, Inc.
$18
Sun Pharmaceutical Industries Inc.
$17
Bausch & Lomb Americas Inc.
$14
Top 3 companies account for 60.1% of all-time payments
Associated products mentioned in payments ›
ACTHAR · ALPHAGAN P · BEOVU · Cequa · Cimerli · Constellation · DEXTENZA · DEXYCU · DURYSTA · EVA · EVA Ophthalmic Surgical System · EYLEA · EYLEA AFLIBERCEPT INJECTION · EYLEA HD · Evrysdi · ILUVIEN · ILUX · Iluvien · Izervay · Lucentis · NGENUITY · Non-Covered Product · OMNI(R) SURGICAL SYSTEM (US) · OZURDEX · P200DTx · PURIFIED CORTROPHIN GEL · SUSVIMO · Syfovre · TECNIS IOL · TEPEZZA · TearCare SmartLid · VABYSMO · VISUDYNE · Vabysmo · XIPERE · YUTIQ · combined machine · rocklatan
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (55%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 8% for retina specialist (ophthalmology) physician in CA.

Looking for a retina specialist physician in Fullerton?
Compare retina specialist physicians in the Fullerton area by procedure volume, costs, and industry payment transparency.
Browse retina specialist physicians nearby

Geographic Context

Retina specialist physicians within 10 mi
20
Per 100K population
0.6
County median income
$113,702
Nearest hospital
PROVIDENCE ST. JUDE MEDICAL CENTER
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Adrean is a mixed practice specialist, with above-average Medicare volume (top 7% in CA), with consulting-driven industry engagement in the top 8% of CA peers, with 19 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Adrean experienced with eye injection (vabysmo/faricimab)?
Based on Medicare claims data, Dr. Adrean performed 38,460 eye injection (vabysmo/faricimab) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Adrean receive payments from pharmaceutical companies?
Yes. Dr. Adrean received a total of $35,077 from 33 companies across 258 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Adrean's costs compare to other retina specialist physicians in Fullerton?
Dr. Adrean's average Medicare payment per service is $61. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Adrean) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →